Blood-based biomarkers for Alzheimer's disease

Chohan, Pruyanka, Dashwood, Mark, Theodoulou, George, Reed, Hannah and Kuruvilla, Tarun (2022) Blood-based biomarkers for Alzheimer's disease. Progress in Neurology and Psychiatry, 26 (4). pp. 10-14. doi:10.1002/pnp.764

Full text not available from this repository.


Blood-based biomarkers for identifying Alzheimer's disease (AD) pathology have been of considerable interest over the past decade and can offer a significant advantage over the currently available and validated cerebrospinal fluid and positron emission tomography biomarkers in terms of cost, invasiveness and accessibility. This review explores the role of three blood-based biomarkers; plasma amyloid beta, tau and neurofilament light chain, and their combination, in the identification of AD pathology and how they may be utilised in clinical practice.

Item Type: Article
Article Type: Article
Uncontrolled Keywords: Mild cognitive impairment; Amyloid-beta-peptide; Plasma; Association; Diagnosis; Alzheimer's disease
Subjects: R Medicine > RC Internal medicine > RC321 Neuroscience. Biological psychiatry. Neuropsychiatry > RC346 Neurology. Diseases of the nervous system
Divisions: Schools and Research Institutes > School of Health
Depositing User: Susan Turner
Date Deposited: 24 Nov 2022 09:46
Last Modified: 24 Nov 2022 09:46

University Staff: Request a correction | Repository Editors: Update this record

University Of Gloucestershire

Bookmark and Share

Find Us On Social Media:

Social Media Icons Facebook Twitter Google+ YouTube Pinterest Linkedin

Other University Web Sites

University of Gloucestershire, The Park, Cheltenham, Gloucestershire, GL50 2RH. Telephone +44 (0)844 8010001.